SHC 2024 Scientific Programme

July, 2024

26

Programme Time (SGT)
Welcome Remarks by the Conference Chairman and SHC partners
Chronic Hepatitis B symposium
Chairs: Prof. Junqi NIU, Prof. Harry Janssen, Prof. Rino Gani
Advances in HBV Cure 2024
Prof. Man Fung Yuen, Hong Kong View Bio
New guidelines for CHB
Prof. Jidong Jia, China View Bio
Debate: Should treatment be expanded
Yes: Prof. Man Fung Yuen, Hong Kong View Bio
No: Prof. Heiner Wedemeyer, Germany View Bio
Stopping nucleoside analogue therapy: worth the risk?
Prof. Harry Janssen, Netherlands View Bio
Update on management of HBV flares
Prof. Teerha Piratvisuth, Thailand View Bio
Round table discussion/Case discussion
GSK Meet the Experts Tea Break
The building blocks of functional cure in HBV: Understanding the mechanisms and clinical considerations
Welcome and introduction
Prof. Lai Wei View Bio
The cornerstone: Defining the mechanisms needed to target functional cure
Dr. Kosh Agarwal View Bio and Prof. Lai Wei View Bio
The keystone: Measuring, monitoring and managing
Dr. Kosh Agarwal View Bio and Prof. Lai Wei View Bio
The capstone: Making functional cure last
Dr. Kosh Agarwal View Bio and Prof. Lai Wei View Bio
Summary and close
Prof. Lai Wei View Bio
Delta Cure Symposium
Chairs: Prof. Teerha Piratvisuth , Prof. Khin Maung Win
What is the prevalence of delta hepatitis and how do you diagnose it
Prof. Pei Jer Chen, Taiwan View Bio
What is delta cure and how to achieve it?
Prof. Pietro Lampertico, Italy View Bio
Treatment options for delta cirrhosis
Prof. Heiner Wedemeyer, Germany View Bio
Round table/case discussion
First GSK Symposium  (lunch)
Functional cure in HBV: Going the distance
Warm up: Introduction and housekeeping
Prof. Tatsuya Kanto View Bio
The functional cure triathlon: HBsAg loss, HBV-DNA suppression, and immune restoration
Prof. Lai Wei View Bio
Personal goals: What could functional cure mean for people living with CHB?
Prof. Thomas Tu View Bio
On the starting line: Current strategies to achieve functional cure
Prof. Tatsuya Kanto View Bio
Taking the torch: Future strategies that could achieve functional cure
Dr. Kosh Agarwal View Bio
Q&A
All Faculty
MASLD Symposium
Chairs: Prof. Yock Young Dan, Dr. Poh Seng Tan, Dr. Yin Mei Lee
NAFLD, MAFLD, MASLD – practical implications of a name change.
Dr. George Goh, Singapore View Bio
Community screening and care pathways in Fatty Liver Disease
Prof. Wah Kheong Chan, Malaysia View Bio
Selecting patients for pharmacological treatment
Prof. Sven Francque, Belgium View Bio
Debate: Vitamin E for NAFLD
Yes: Prof. Arun Sanyal, USA View Bio
No: Prof. Vincent Wong, Hong Kong View Bio
Pearls and pitfalls on how to use GLP1 agonists
Dr. Mark Muthiah, Singapore View Bio
Summary of the Second Singapore MASLD Symposium
Prof. Arun Sanyal, USA View Bio
Round table/case discussion
Fireside Chat with Hepatology experts: career pearls for clinicians and researchers
Moderator: Dr. Daniel Huang
Featuring Prof. Rajender Reddy, View Bio Dr. Anand V Kulkarni, India View Bio & Prof. Arun Sanyal, USA View Bio
End of day 1

July, 2024

27

Programme Time (SGT)
HCC Symposium
Chairs: Dr. Edhel Tripon, Dr. Wei Lyn Yang, Adj. A/Prof. Chee Cheng Ean
Hepatocellular surveillance: Barriers, gaps and new strategies
Dr. Ken Liu, Australia  View Bio
Role of non-invasive tests in NASH and HCC risk
Dr. Daniel Huang, Singapore View Bio
Debate: Adjuvant therapy for HCC Cure
Yes: Prof. Pierce Chow, Singapore
View Bio
No: Prof. Glenn Bonney, Singapore View Bio
Updates in systemic therapy for HCC: the way forward
–  Adj. A/Prof. Chee Cheng Ean, Singapore View Bio
Round-table /case discussion
Tea Break
Other Liver Diseases 
Chairs: Dr. How Cheng Low, Dr. Kieron Lim, Prof. Bettina Hanssen
The forgotten disease: Alcoholic liver disease & MetALD
Prof. Ajay Duseja, India View Bio
Difficult to treat autoimmune hepatitis
Prof. Atsushi Tanaka, Japan View Bio
Biliary cirrhosis and sclerosing cholangitis: Update
Prof. Atsushi Tanaka, Japan View Bio
When should we consider rare liver diseases and how to diagnose it?
Prof. Bettina Hanssen, Holland View Bio
Round table/case discussion
Lunch 
Advanced Liver Disease Management for the practising gastroenterologist/hepatologist
Chairs: Dr. Rinaldi Lesmana, Prof. Raj Reddy
Hepatorenal syndrome and point of care ultrasound.
Dr. Anand V Kulkarni, India View Bio
Acute on chronic liver failure
Prof. Ajay Duseja, India View Bio
Preventing progression and complications of cACLD.
Dr. Ken Liu, Australia  View Bio
When to refer patients for liver transplantation
Dr. Ruveena Bhavani Rajaram, Malaysia View Bio
Futility in liver transplantation
Prof. Rajender Reddy, USA View Bio
Round table/cases discussion
Closing comments from the Chairman